0001628280-24-028052.txt : 20240613
0001628280-24-028052.hdr.sgml : 20240613
20240613161651
ACCESSION NUMBER: 0001628280-24-028052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240612
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HAUSMAN DIANA
CENTRAL INDEX KEY: 0001563992
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40675
FILM NUMBER: 241041439
MAIL ADDRESS:
STREET 1: C/O ONCOTHYREON INC.
STREET 2: 2601 FOURTH AVE, SUITE 500
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER NAME:
FORMER CONFORMED NAME: HAUSMAN DIANE
DATE OF NAME CHANGE: 20121207
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immuneering Corp
CENTRAL INDEX KEY: 0001790340
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-500-8080
MAIL ADDRESS:
STREET 1: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wk-form4_1718309804.xml
FORM 4
X0508
4
2024-06-12
0
0001790340
Immuneering Corp
IMRX
0001563992
HAUSMAN DIANA
245 MAIN STREET
2ND FLOOR
CAMBRIDGE
MA
02142
1
0
0
0
0
Stock Option
1.54
2024-06-12
4
A
0
33350
0
A
2034-06-12
Class A Common Stock
33350
33350
D
The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 12, 2024, and will be fully vested and exercisable on June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first.
/s/ Michael D. Bookman, Attorney-in-Fact for Diana F. Hausman
2024-06-13